Lifting weights lowered blood pressure in pooled trials

Hypertension is a major contributor to cardiovascular illness and death, and non-drug strategies to help control it are of obvious interest. Resistance training has been proposed as one such strategy, but its clinical relevance in hypertensive adults has remained unclear because trials differ markedly in method and in how the training was prescribed. Scattered small studies make it hard to tell whether the effect is reliable and how big it actually is. This review set out to pool the randomised evidence for systolic and diastolic blood pressure, with explicit emphasis on effect magnitude and cautious interpretation of clinical relevance.

The authors systematically searched Scopus, PubMed, EBSCOhost and Web of Science from database inception to 1 June 2026. Randomised controlled trials were eligible if they enrolled adults with hypertension or elevated blood pressure, tested a resistance training intervention, and reported systolic and diastolic blood pressure both before and after the intervention. Twelve randomised controlled trials met these criteria. Results were combined as standardised mean differences with 95% confidence intervals using inverse-variance random-effects models, and heterogeneity between studies was quantified with the I2 statistic for each outcome.

Resistance training significantly reduced systolic blood pressure relative to control or comparator groups, with a moderate pooled effect (SMD = -0.77; 95% CI -1.06 to -0.48; p < 0.00001) and modest heterogeneity (I2 = 35%). Diastolic blood pressure also fell significantly, but with a smaller pooled effect (SMD = -0.43; 95% CI -0.67 to -0.19; p = 0.0003) and no detectable heterogeneity (I2 = 0%). Importantly, because individual participant data and categorical transition analyses were unavailable, the authors state the evidence does not confirm systematic reclassification across AHA/ACC blood pressure categories. They call for standardised protocols and analyses reporting absolute changes in mmHg.

This supports the existing proposition that resistance training belongs among non-pharmacological blood pressure strategies, and it strengthens that case by pooling randomised trials rather than relying on single studies. The low heterogeneity for diastolic pressure suggests a fairly consistent signal across trials. What it does not do is translate statistical effect sizes into the mmHg figures clinicians and patients actually use, or show that anyone moved from a hypertensive to a normal category. Variability in how resistance training was prescribed across the 12 trials remains the central unresolved issue.

This is a reason to think resistance training has a genuine, measurable effect on blood pressure in people with hypertension or elevated readings, with the systolic effect larger than the diastolic one. The authors are direct that it should be considered complementary to pharmacological treatment rather than an alternative to it. Because the results are reported as standardised effect sizes, you cannot read off how many mmHg a given programme might shift. Anyone managing high blood pressure would keep decisions about medication with their own clinician.},